
    
      This study is a post-market clinical follow-up (PMCF) study to monitor the safety, lifetime
      and efficacy of patients using the CE-certified RETINA IMPLANT Alpha AMS. For Germany, it is
      under the exceptions mentioned in ยง23b MPG (Medizinproduktegesetz, German Medical Device
      Law). Its purpose is to collect data that is created during the regular therapy with the
      implant. No additional examinations are performed, except a patient questionnaire.
    
  